Technologies (NASDAQ: DVAX) fell 6% Tuesday after Goldman Sachs issued a rare "sell" rating on the biopharmaceutical company, ...

Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...

Goldman Sachs analysts said gold remains its "highest ... "We are very pleased with the results of the successful extensive prospecting program on the property which found 20 historic mine shafts ...

Bank of America Securities analyst Ebrahim Poonawala maintained a Buy rating on Goldman Sachs Group (GS – Research Report) today. The company’s ...

That said, the stock has been on fire, surging 116% since November 2023 as the investment bank crushed earnings expectations last year. Looking ahead, Goldman Sachs anticipates a meaningful shift that ...

Goldman Sachs (GS) is ending the pledge it made to refuse IPO business with companies that had all White, male boards, Bloomberg’s Sridhar ...

Goldman Sachs CEO David Solomon was awarded an $80 million stock bonus to stay at the helm for another five years, a stark turnaround for a leader whose survival was questioned after the firm's ...

Billionaire investor Ray Dalio's Bridgewater Associates took a new stake in Tesla among its Q4 moves. Read more here.

BILL (NYSE:BILL – Free Report) had its target price cut by The Goldman Sachs Group from $104.00 to ... Several other equities research analysts have also weighed in on the stock.

Tapestry (NYSE:TPR – Free Report) had its price objective raised by The Goldman Sachs Group from $72.00 ... A number of other analysts also recently commented on TPR. Wells Fargo & Company ...

according to Goldman Sachs Group Inc. economists. The analysts see net immigration to the US plummeting to 750,000 a year, shaving 30-40 basis points (0.3-0.4 percentage points) off potential ...